Cardiovascular outcomes in adults with migraine treated with eptinezumab for migraine prevention: pooled data from four randomized, double-blind, placebo-controlled studies

Abstract Background Patients with migraine have an increased relative risk of cardio- and cerebrovascular events, and some migraine treatments may exacerbate this risk. The primary objective of this analysis was to determine whether the rate of cardiovascular adverse events was higher for patients w...

Full description

Saved in:
Bibliographic Details
Main Authors: Timothy R. Smith, Egilius L. H. Spierings, Roger Cady, Joe Hirman, Anders Ettrup, Vivienne Shen
Format: article
Language:EN
Published: BMC 2021
Subjects:
R
Online Access:https://doaj.org/article/86ab8c5590de45cab7f535c82db50e55
Tags: Add Tag
No Tags, Be the first to tag this record!